• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 144700-19
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Restenosis (4576)
Event Date 03/02/2022
Event Type  Injury  
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of restenosis leading to intervention is listed in the biomimics 3d instructions for use and is a known patient effect of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Event Description
The patient was treated as part of the mimics 3d usa post-market observational study on (b)(6) 2021.The subject was implanted with one biomimics 3d (bm3d) stent (a 7.0 x 150mm stent) to treat a restenotic lesion of the sfa middle third to sfa distal third artery in the right leg.A contralateral approach was used and the lesion was prepared using pre-dilatation with percutaneous transluminal angioplasty (pta) and laser atherectomy.The treated segment was post-dilated with pta.On (b)(6) 2022, an event of restenosis of treated segment (target lesion) was identified by the site.It was reported as "not related" to the device and "not related" to the procedure but worsening pre-existing condition.It was target lesion-related.The right sfa stent was treated with plain old balloon angioplasty (poba) for in-stent restenosis (isr).The right ostial sfa stenosis was treated with laser atherectomy and poba.The intervention was performed on (b)(6) 2022 and the segment treated was the sfa ostial to proximal popliteal.The patient outcome was reported as "resolved/recovered".It was reported as a target lesion revascularisation (tlr) and target vessel revascularisation (tvr).The device remains implanted.This was reviewed by veryan on 05-mar-24 and considered possibly related to the bm3d device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
block 5
parkmore east business park
galway, H91 V 0TX
EI  H91 V0TX
Manufacturer Contact
alan mcdonagh
block 5
parkmore east business park
galway, H91 V-0TX
EI   H91 V0TX
MDR Report Key19032790
MDR Text Key339249277
Report Number3011632150-2024-00014
Device Sequence Number1
Product Code NIP
UDI-Device Identifier05391526850527
UDI-Public(01)05391526850527(17)220611(11)201110(10)0000056112
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Catalogue Number144700-19
Device Lot Number0000056112
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/05/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/10/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASPIRIN.; CILOSTAZOL (PLETAL).; CLOPIDOGREL (PLAVIX).
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexFemale
Patient Weight72 KG
Patient EthnicityHispanic
-
-